(Q40919306)

English

Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy

scientific article

Statements

Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy (English)
6 February 2016

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit